completed

The overarching goal of the MIPAD study was to reduce the morbidity and mortality of post-MI patients through improved long-term cardiac medication adherence.

The specific objectives include:

  • To assess the impact on long-term cardiac medication adherence following the implementation of a standardized process to increase in discharge prescription length to 90-days with three repeats in post-MI patients as compared to education alone and usual care.
  • To assess the cost implications of the prolonged initial discharge prescriptions as compared to usual care.
  • To compare clinical outcomes between longer (>60 days) versus shorter prescription durations.
  • To collect baseline information to inform a multi-centre interventional study (i.e., simple monthly proportions of 1-year adherence by hospitals in Ontario).

Dr. Noah Ivers, TorontoNoah Ivers was Co-PI on the MIPAD study with JD Schwalm.

Study Type

Observational

Study Design

Quasi-experimental, controlled interrupted time series

NO. of Countries

1

NO. of Sites

4

NO. of Participants

8000

Study Period

2017-2019

Sponsor

PHRI

Back To Top